Reelin, GABA, FMRP, and autism

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Autism is a heterogeneous neurodevelopmental disorder. The etiology of autism remains unknown although both genetic and environmental factors are likely to be involved. These factors disrupt the course of normal brain development from the cellular to the gross anatomical levels. The Reelin, gamma-aminobutyric acid (GABA), and fragile X mental retardation protein (FMRP)-metabotropic glutamate receptor 5 (mGluR5) signaling systems play important roles during the development of the nervous system. Disruption of these pathways is likely to lead to altered synaptic transmission and, ultimately, the cognitive and behavioral deficits associated with autism. This chapter describes each of these signaling systems and summarizes the current evidence that link them to autism. Therapies that target molecules in these signaling systems may provide new means of treating the core symptoms of autism.

Original languageEnglish (US)
Title of host publicationThe Molecular Basis of Autism
PublisherSpringer New York
Pages337-359
Number of pages23
ISBN (Electronic)9781493921904
ISBN (Print)9781493921898
DOIs
StatePublished - Jan 1 2015

Keywords

  • Brain
  • FMRP
  • GABA
  • Reelin
  • mGluR5

Fingerprint Dive into the research topics of 'Reelin, GABA, FMRP, and autism'. Together they form a unique fingerprint.

  • Cite this

    Folsom, T. D., & Fatemi, S. H. (2015). Reelin, GABA, FMRP, and autism. In The Molecular Basis of Autism (pp. 337-359). Springer New York. https://doi.org/10.1007/978-1-4939-2190-4_16